Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FLJPB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,474
Award facts
- Contract value 100% obligated
- $11,474.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Wegovy 2.4 mg/0.75 mL pen injectors valued at $11,474.20, with completion scheduled for September 29, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which has a ceiling value of $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support program enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds significant federal procurement responsibility through its DLA contract portfolio. The company's demonstrated capability to compete successfully across open procurement processes, combined with its extensive experience delivering specialty medications and brand-name drugs to military and veteran healthcare systems, positions it as a critical vendor for federal medical supply needs. This specific delivery order for Wegovy, a GLP-1 receptor agonist used for weight management and diabetes treatment, reflects DLA's pharmaceutical sourcing requirements within the broader context of military healthcare support.
Quick answers
Who was awarded contract SPE2DB25FLJPB?
SPE2DB25FLJPB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FLJPB worth?
The government has obligated $11,474 on SPE2DB25FLJPB.
Is contract SPE2DB25FLJPB an order under another contract?
Yes. SPE2DB25FLJPB is a delivery order under SPE2DB24D6044, an indefinite delivery contract.
Was contract SPE2DB25FLJPB competed?
The extent of competition for SPE2DB25FLJPB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award